Total Active Patients
11,581
Est: 9,032 · New: 2,549
↑ +7.0% Net Growth MoM
Established Net Income
+22.1%
14 Clinics · YTD Segment Median
↑ Target exceeded (+3.1pp)
Combined Gross Margin
69.6%
Network Average (Blended)
↑ Efficiency +9.6pp vs 2025
Startup Net Income
-41.8%
20 Clinics · Maturity Cycle Avg
↑ Improving from -66.9%
Patients / FT Employee
110.3
Old Segment Peak: 160.4
↑ Utilization +7.0% Peak
Avg Churn Rate
3.2%
Network Target: ≤ 2.5%
↗ Retention Focus Required
Profitability Trend by Cohort (Net Income %)
Established Cohort
Startup Cohort
Patient Acquisition & Retention Balance
New Acquisitions
Attrition
Segment Performance Snapshot — Established
2024 Final
+11.6%
Net
2025 Final
+19.0%
Net
2026 YTD
+22.1%
Net
Gross Margin Trend
68.3%Current
67.9%Prev
Operational Expense / Rev
45.3%Target
48.4%Prev
Clinical Utilization (P/FTE)
160.4Current
120.3Prev
Segment Performance Snapshot — Startup
2024 Final
-305%
Net
2025 Final
-66.9%
Net
2026 YTD
-41.8%
Net
Gross Margin Trend
72.6%Current
63.0%Prev
Operational Expense / Rev
112.2%Current
118.9%Prev
Conversion Efficiency (Mktg/R)
4.38%Current
9.95%Prev
Strategic Insights
NETWORK EFFICIENCY SURGE
Established locations have achieved a record 22.1% net income margin. Labor utilization (160.4 P/FTE) is up 33% year-over-year, confirming that optimized workflows are scaling as patient volume increases.
STARTUP MATURITY CURVE
Startup clinics are transitioning towards break-even faster than previous cohorts. Gross margins at 72.6% indicate that early-stage variable costs are well-controlled, significantly outperforming legacy cohort launch metrics.
ATTRITION ALERT
The blended churn of 3.2% is above the 2.5% threshold. Specific locations (ID 309, 316, 317) show churn exceeding 7%. Review of patient engagement protocols at these sites is mandated for Q2.
Gross Margin Development (12 Months)
Established
Newer
Operating Expense Leverage Analysis
Established
Newer
Revenue Per Patient Correlation
Established
Newer
Marketing Spend Efficiency (% of Rev)
Established
Newer
Diagnostic Volume
889
Est: 583 · New: 306
Advanced Therapies
614
Est: 388 · New: 226
Preventative Care
434
Segment Shift: -4% Feb
Retention Analysis (Churn %)
Established Segment
Startup Segment
Patient Ecosystem Distribution
Comprehensive Location Matrix (Feb-26 Spot Check)
| Clinic ID & Area | Cohort | Active Patients | Margin (2025) | Margin (YTD) | Net % (2025) | Net % (YTD) | OpEx / R | Revenue/P | Churn Rate | Executive Status |
|---|
Top Locations by Net Income Contribution (2025)
Gross Margin Benchmarking (2025)
Medical Clinic Corporation · System Dashboard · CONFIDENTIAL · 2026-02-28